메뉴 건너뛰기




Volumn 7, Issue 6, 2008, Pages

Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE; NICOTINIC ACID DERIVATIVE; TAZAROTENE;

EID: 52449098520     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (35)

References (12)
  • 1
    • 0028912340 scopus 로고
    • The evaluation and management of acne: Economic considerations
    • Bergfeld WF. The evaluation and management of acne: economic considerations. J Am Acad Dermatol. 1995;32:S52-S56.
    • (1995) J Am Acad Dermatol , vol.32
    • Bergfeld, W.F.1
  • 2
    • 0033584178 scopus 로고    scopus 로고
    • Acne and acne scarring: Why should we treat?
    • Goodman GJ. Acne and acne scarring: why should we treat? Med J Aust. 1999;171:62-63.
    • (1999) Med J Aust , vol.171 , pp. 62-63
    • Goodman, G.J.1
  • 3
    • 0034650247 scopus 로고    scopus 로고
    • Topical therapy for acne
    • Russell JJ. Topical therapy for acne. Am Fam Physician. 2000;61:357-366. (Pubitemid 30067471)
    • (2000) American Family Physician , vol.61 , Issue.2 , pp. 357-366
    • Russell, J.J.1
  • 4
    • 22144473717 scopus 로고    scopus 로고
    • Mechanism-based treatment of acne vulgaris: The value of combination therapy
    • Webster G. Mechanism-based treatment of acne vulgaris: the value of combination therapy. J Drugs Dermatol. 2005;4:281-288.
    • (2005) J Drugs Dermatol , vol.4 , pp. 281-288
    • Webster, G.1
  • 5
    • 0033834908 scopus 로고    scopus 로고
    • New treatments and therapeutic strategies for acne
    • Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med. 2000;9:179-187.
    • (2000) Arch Fam Med , vol.9 , pp. 179-187
    • Thiboutot, D.1
  • 8
    • 39049180065 scopus 로고    scopus 로고
    • Treatment considerations for inflammatory acne: Clinical evidence for adapalene 0.1% in combination therapies
    • Thiboutot DM, Gollnick HP. Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies. J Drugs Dermatol. 2006;5:785-794.
    • (2006) J Drugs Dermatol , vol.5 , pp. 785-794
    • Thiboutot, D.M.1    Gollnick, H.P.2
  • 9
    • 0035377873 scopus 로고    scopus 로고
    • Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: A randomized trial
    • Leyden J, Lowe N, Kakita L, Draelos Z. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial. Cutis. 2001;67:10-16.
    • (2001) Cutis , vol.67 , pp. 10-16
    • Leyden, J.1    Lowe, N.2    Kakita, L.3    Draelos, Z.4
  • 10
    • 0036479373 scopus 로고    scopus 로고
    • A multicenter, doubleblind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris
    • Webster GF, Guenther L, Poulin YP, et al. A multicenter, doubleblind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002;69:4-11.
    • (2002) Cutis , vol.69 , pp. 4-11
    • Webster, G.F.1    Guenther, L.2    Poulin, Y.P.3
  • 12
    • 3242807326 scopus 로고    scopus 로고
    • Adapalane: A review of its use in the treatment of acne vulgaris
    • DOI 10.2165/00003495-200464130-00005
    • Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs. 2004;64:1465-1478. (Pubitemid 38980458)
    • (2004) Drugs , vol.64 , Issue.13 , pp. 1465-1478
    • Waugh, J.1    Noble, S.2    Scott, L.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.